Ohio Cannabis News This Week: New THC Rules Hit Consumers as Federal Rescheduling Faces Another Delay

October 16, 2026 | Ohio Cannabis Live

Ohio cannabis consumers are dealing with big changes at home while the federal marijuana rescheduling fight has hit another delay. This week brought new questions about product limits, packaging, pricing, advertising rules and what happens next with Schedule III.

Here’s what matters right now in Ohio and across the country.

Ohio THC and Packaging Changes Are Starting to Hit Consumers

Ohio’s new cannabis product rules are changing what consumers see on dispensary shelves. Adult-use edibles are generally limited to 10 milligrams of THC per serving and 100 milligrams per package, and the state has also issued updated guidance covering packaging, labeling and THC-content limits for other product categories.

That sounds technical, but the effect at the register can be simple: some consumers may have to buy more packages to get the same total amount of THC they were buying before. That raises a real question about whether people will end up paying more for less convenient packaging.

The Ohio Division of Cannabis Control has continued issuing guidance as the rules roll out. Its supplemental guidance page lists an Advertising Guidance Update issued October 5, along with Packaging and Labeling tips issued September 25 and THC-content guidance issued August 6.

Source: Ohio Division of Cannabis Control

Ohio Cannabis Advertising Rules Are Still Changing

Ohio businesses also have to keep watching how they market cannabis. Current state rules prohibit advertising aimed at minors, obscene or indecent content, unverified health claims and misleading information.

For operators, this is another reminder that compliance is not something you check once and forget. The rules and guidance continue to evolve, and businesses need to keep up.

Source: Ohio Cannabis FAQ

Federal Marijuana Rescheduling Is Delayed Again

The biggest national cannabis story this week is the ongoing marijuana rescheduling case.

DEA Chief Administrative Law Judge Derek Julius ordered the agency on October 14 to respond to a new request from opponents of rescheduling who want additional testimony and document discovery tied to a recent Government Accountability Office report.

DEA’s response is due October 21.

The important part: the proceeding is still stayed while the judge considers the pending motions. That means the Schedule III process has been delayed again, but it has not been canceled.

Source: Marijuana Moment

Why the GAO Report Matters

The Government Accountability Office released a report on September 23 examining how DEA and FDA handle federal drug scheduling decisions.

GAO found gaps in the agencies’ written policies and procedures. Among other things, the report said DEA does not have comprehensive policies identifying roles, responsibilities and procedures for scheduling evaluations, while FDA does not fully specify how staff should conduct evaluations and develop scheduling recommendations.

Opponents of marijuana rescheduling are using those findings to argue for more testimony and discovery. DEA has said it does not object to the GAO report being considered, but disputes the idea that the report undermines the marijuana rescheduling case.

Source: U.S. Government Accountability Office

What This Means for Ohio

Ohio cannabis consumers and businesses are dealing with changes from two directions at once.

At the state level, regulators are changing product limits, packaging, labeling and advertising rules. At the federal level, the government is still deciding how marijuana should be classified under the Controlled Substances Act.

Moving marijuana to Schedule III would be a major federal policy change, but it would not be the same thing as nationwide recreational legalization. Ohio would still have its own licensing system, product rules and regulatory structure.

Federal changes could eventually affect cannabis research, taxation, business operations and the relationship between state programs and federal law, but there are still a lot of unanswered questions.

What We’re Watching Next

The next major federal date is October 21, when DEA is due to respond to the latest motion in the rescheduling case.

Here in Ohio, we’ll be watching how the new THC and packaging rules affect product availability and pricing at dispensaries.

Are you paying more for products that contain less THC? Are products you used to buy disappearing from shelves? Ohio Cannabis Live wants to hear what consumers and patients are actually experiencing.

Follow Ohio Cannabis Live for independent Ohio cannabis news, interviews, legislative coverage and industry updates. And catch our weekly Friday show for a breakdown of the stories affecting Ohio and the national cannabis industry.